|
|
Thalassemia
Topic Overview

What is thalassemia?
Thalassemia (say "thal-uh-SEE-mee-uh") is an
inherited blood disorder that causes the body to produce less
hemoglobin.
Hemoglobin helps red blood cells spread oxygen all
through your body. Low levels of hemoglobin may cause anemia, an illness that
makes you feel weak and tired. Severe cases of anemia may damage organs and
result in death.
What causes thalassemia?
A defect in one or more
genes causes thalassemia. It is an inherited blood
disorder, passed from parent to child. Both parents must carry a gene for the
disease in order to pass it to their child.
What are the types of thalassemia?
Alpha thalassemia and beta thalassemia are the two main types of
the disease. Beta is the most common form. A "carrier" has one normal gene and
one thalassemia gene in all body cells, a state sometimes called "thalassemia
trait." Most carriers lead completely normal, healthy lives.
Beta thalassemia
Beta thalassemia occurs when one or both of the genes that
produce beta-globin don't work or only partly work the way they should. People
need both alpha- and beta-globin to make hemoglobin. Beta thalassemia mainly
affects people from the region around the Mediterranean Sea (such as Greeks and
Italians) and, less often, people of African or Asian descent.
There are several subtypes of beta thalassemia. Which type you
have depends upon whether one or both genes are affected and whether those
genes still produce some working beta-globin.
- If you carry the genetic trait for
thalassemia or have one damaged beta-globin gene, you may have mild anemia and
probably will not need treatment. This condition is called beta
thalassemia minor or beta thalassemia trait. You
have thalassemia trait when you inherit a normal gene from one parent and a
thalassemia gene from the other.
- When both beta-globin genes are
damaged, moderate or severe anemia may develop. In this situation, you have
inherited a thalassemia gene from each parent.
- If you have moderate anemia (beta thalassemia intermedia), you may need
blood transfusions. People who have beta thalassemia
intermedia usually live into adulthood.
- People with severe anemia
(called beta thalassemia major or Cooley's anemia) usually will not live into adulthood without
treatment. Symptoms of anemia usually develop within 6 months of birth.1 If the child starts receiving blood transfusions early and
continues to receive them throughout life, he or she is likely to live longer.
Death is usually a result of damage to organs, such as the heart or liver. Lack
of oxygen or an iron overload from blood transfusions causes the organ
damage.
Alpha thalassemia
Alpha thalassemia occurs when one or more of the four genes that
are vital to making hemoglobin are missing or damaged. Alpha thalassemia mainly
affects people from southeast Asia, China, and the Philippines, although it
occurs in many populations throughout the world. It is sometimes seen in people
of African descent.
There are four subtypes of alpha thalassemia. Each type
represents the loss of or damage to one, two, three, or four genes.
-
One gene: If one
alpha-globin gene is missing or damaged, you will have no symptoms and will not
need treatment. But you are a silent carrier. This means
you don't have the disease but you can pass the defective gene onto your child.
Smaller-than-normal blood cells may be the only sign of the condition.
-
Two genes: If two alpha-globin genes are
missing or damaged, you will have very mild
anemia that will not need treatment. This is known as
alpha thalassemia minor or alpha
thalassemia trait.
-
Three genes: If
three alpha-globin genes are missing, you will have mild to moderately severe
anemia. This is sometimes called hemoglobin H disease,
because it produces a heavy hemoglobin. The body removes this heavy hemoglobin
faster than it does normal hemoglobin. The more severe forms may need treatment
with
blood transfusions.
-
Four
genes: If all four alpha-globin genes are missing (alpha
thalassemia major), the fetus will be stillborn or the child will die
shortly after birth.1 The hemoglobin produced by this
condition is sometimes called hemoglobin Barts.
What are the symptoms?
Mild thalassemia usually does not cause any symptoms. But symptoms
of anemia may develop in more severe forms of the condition and may
include:
- Weakness.
- Fatigue.
- Lightheadedness.
- Skin that looks paler than normal.
- Jaundice (skin and whites of the eyes appear
yellow).
- Dark urine.
- Decreased appetite and weight loss
(poor growth in a child).
- A rapid heartbeat.
- Shortness
of breath during exercise.
How is thalassemia diagnosed?
A physical exam and complete medical history are usually the first
steps in diagnosing thalassemia. Tests that help confirm a diagnosis of
thalassemia include:
-
Complete blood
count (CBC) and blood smear.
-
Gene
test.
- Iron level test, to determine whether
iron deficiency anemia is present.
- A
blood test that measures the amounts of different types of hemoglobin
(hemoglobin electrophoresis), to help find out which type of thalassemia you
have.
- A complete blood count (CBC) test on other members of your
family (parents and siblings), to discover whether they may also have
thalassemia.
How is it treated?
Treatment for thalassemia depends on your symptoms.
- Mild thalassemia, the most common form, does
not need treatment.
- Moderate thalassemia may be treated with
folic acid supplements and
blood transfusions.
- Severe thalassemia may
be treated with:
- Blood transfusions.
- Folic
acid.
- A splenectomy, which is surgical removal of the
spleen.
- A bone marrow transplant, in some severe cases.
Very rare forms of thalassemia may cause organ damage that can
result in death. This damage occurs when not enough oxygen reaches the organs.
Iron overload also may damage organs, especially the liver. The body can get
too much iron through repeated blood transfusions. If this happens, your doctor
may give you
chelating therapy. Or you may get medicine that binds
to the iron in your body and removes it through your urine or stool. You may
take this medicine as pill or have it pumped under your skin through a thin
tube.
Frequently Asked Questions
|
Learning about
thalassemia:
|
|
|
Being diagnosed:
|
|
|
Getting treatment:
|
|
|
Living with thalassemia:
|
|
Symptoms
Mild
thalassemia usually does not cause any symptoms.
People who have more severe forms of the condition may develop
symptoms of
anemia, which may include:
- Weakness.
- Fatigue.
- Lightheadedness.
- Skin that looks paler than normal.
- Jaundice (skin and whites of the eyes appear
yellow).
- Dark urine.
- Decreased appetite and weight loss
(poor growth in a child).
- A rapid heartbeat.
- Shortness
of breath during exercise.
Less common symptoms of severe thalassemia include:
- Headache.
- Belly
pain.
- Ringing in the ears.
- Chest pain.
- A
slight fever.
- A sore, smooth tongue.
Children with a more severe form of thalassemia (beta thalassemia
major, or Cooley's anemia) usually develop symptoms of
anemia within the first few months of life. Paler skin
is often the first sign of the disease.2 Infants may
grow slowly (failure to thrive). Other symptoms may include feeding
problems, frequent fevers, and diarrhea. Without early treatment, a child may
die or develop severe problems, such as:3
- A deformed face caused by the
bone marrow expanding in the bones. This may cause a
bulging forehead (frontal bossing).
- An enlarged
liver
and
spleen.
- Brittle, weak bones (most often
the long bones in legs and arms and the bones of the spine).
Related problems of severe thalassemia may include:
- Severe bacterial infections. An annual flu shot
and the pneumonia vaccine may protect you from severe infections, which can
make
anemia worse in people with thalassemia.
- Organ damage. Many blood transfusions over time can lead to
higher levels of iron stored in the body. The body stores this excess iron in
the liver, heart, and other organs. In time, too much iron in these organs
(iron overload) may cause damage. To reduce the amount of iron in your body,
your doctor may treat you with
chelating therapy. Or you may get medicine that binds
to the iron in your body and removes it through your urine or stool. You may
take this medicine as pill or have it pumped under your skin through a thin
tube.
Exams and Tests
A physical exam and complete medical history are usually the first
steps in diagnosing
thalassemia. Your medical history includes:
- Your symptoms.
- Your ethnic
background.
- The general health of close family
members.
- Any other health conditions you may have.
- Any
blood tests that you have had.
Results of tests reveal important information, such as the type of
thalassemia. Tests that help confirm a diagnosis of thalassemia include:
-
Complete blood count (CBC) and blood
smear.
- Blood cells are checked for their shape,
color, number, and size. These features help your doctor know whether you have
thalassemia and, if so, what type.
- These tests also tell your
doctor if you have mild, moderate, or severe
anemia.
- Tests for the
genes that often cause thalassemia.
- Blood
tests that measure the amount of iron in the blood (iron level tests and a
ferritin test).
- A blood test that
measures the amounts of different types of hemoglobin (hemoglobin
electrophoresis). The results help determine the type of thalassemia you
have.
- A complete blood count (CBC) on other members of your family
(parents and siblings), to determine whether they have thalassemia.
Doctors often diagnose the most severe form of thalassemia (beta
thalassemia major, or Cooley's anemia) within the first year of a child's life.
Treatment Overview
Treatment for
thalassemia depends on the severity of the condition.
Thalassemia may be mild, moderate, or severe.
Mild thalassemia is the most common form and
does not require treatment.
Moderate thalassemia (thalassemia intermedia
and more severe hemoglobin H disease) may be treated with:
-
Folic acid (a vitamin that your body
needs to produce new red blood cells). People with thalassemia often lack
enough folic acid in their diets to keep a good supply of red blood
cells.
-
Blood transfusions. You may need a
blood transfusion when your body is under stress, such as during an
infection.
If you have moderate thalassemia, do not take medicines that
increase the amount of iron in the body, which can damage organs. These
medicines include:
- Iron supplements or multivitamins that contain
iron.
- Vitamin C, which can increase the amount of iron that your
body absorbs from food.
Severe thalassemia is often treated
with:
- Regular
blood transfusions. A child with severe thalassemia
typically starts to have symptoms when he or she is 6 months old and will need
blood transfusions every 4 to 6 weeks. The transfusions often lead to increased
iron levels, which also may require treatment.
-
Folic acid, which your body needs to produce red blood
cells. A person with thalassemia needs folic acid supplements because red blood
cells are destroyed faster than normal. As a result, the body often uses up its
stores of this vitamin.
Other treatments that doctors consider for severe cases of
thalassemia include:
- A
splenectomy, which is surgical removal of the
spleen.
- In rare cases, a bone marrow
transplant. This treatment can cure severe thalassemia, but it must be done
before problems related to excess iron stored in the body develop.
Phlebotomy, removing blood from the body, is sometimes
needed after a successful bone marrow transplant to reduce high iron levels.
- In rare cases, a
stem cell transplant.2 This
procedure involves taking stem cells from the umbilical cord of a newborn.
These stem cells are then injected into a child who has severe thalassemia. The
donor is most often a brother or sister of the child.
What to Think About
Blood transfusion therapy often creates an excess of iron, which
may damage organs if untreated. You may need to use medicines called chelating
agents that bind to and remove excess iron from the blood. The chelating agent
deferasirox (Exjade) is taken as a pill once a day. The chelating agent
deferoxamine mesylate (Desferal) is injected through a tube placed under the
skin. A portable pump delivers the medicine in what is usually an all-night
procedure. This treatment works best if it is done 5 or 6 nights a week. Both
deferoxamine and deferasirox have potentially serious side effects, including
hearing loss and kidney, liver, and eye problems.
Researchers are studying how well medicines (hydroxyurea and
butyrate) work to get the body to produce fetal hemoglobin in children and
adults with thalassemia. Fetal
hemoglobin is different than adult hemoglobin. The
body does not normally produce it after birth. Fetal hemoglobin may help adult
hemoglobin work better in people with thalassemia.4
Home Treatment
If you have
blood transfusions to treat your
thalassemia, you need to avoid vitamins that increase
iron stored by the body. Excess iron can cause serious damage to your organs.
Avoid the following vitamins:
- Multivitamins that contain iron.
- Vitamin C, which can
increase the amount of iron you absorb from food.
You may want to get flu shots once a year. Talk to your doctor
about getting a pneumonia shot. These shots may protect you from severe
infections, which can make
anemia worse in people with thalassemia.
It is also important to get help from people who are specially
trained in the medical and emotional effects of thalassemia. Talk to your
doctor about organizations that can help you cope with the impact this disease
has on you and your family.
If you or any of your family members (parents or siblings) have
thalassemia or thalassemia trait and you are thinking about having a child, you
may want to talk to a health professional who specializes in the study of
inherited disorders (genetic
counselor) before you become pregnant. A genetic counselor can tell you
how likely it is that your child will have thalassemia and how severe it might
be.
Other Places To Get Help
Organizations
| Centers for Disease Control, Hereditary Blood Disorders
Team |
| 1108 Corporate Square |
| Atlanta, GA 30329 |
| Phone: | 404-639-8040 |
| E-mail: | hdb@cdc.gov |
| Web Address: | www.cdc.gov/ncbddd/hbd/default.htm |
| |
|
The Hereditary Blood Disorders Team of the Centers for Disease
Control works to prevent and reduce complications experienced by people with
certain hereditary blood disorders: bleeding disorders, thrombophilia (clotting
disorders), and thalassemia.
|
|
| Cooley's Anemia Foundation |
| 330 Seventh Avenue |
|
Suite 900 |
| New York, NY 10001 |
| Phone: | 1-800-522-7222 |
| Fax: | (212) 279-5999 |
| E-mail: | info@cooleysanemia.org |
| Web Address: | www.cooleysanemia.org |
| |
|
Cooley's Anemia Foundation is a nonprofit organization dedicated to
serving people afflicted with various forms of thalassemia, most notably the
major form of this genetic blood disease, Cooley's anemia (thalassemia major).
The foundation's mission is to advance the treatment and cure for thalassemia,
enhance the quality of life of people who have it, and educate the medical
profession, trait carriers, and the public about this fatal blood disease. The
foundation encourages donations of blood, since thalassemia patients are the
single largest users of blood supplies in the nation, and also sponsors
chapters and support groups.
|
|
| March of Dimes |
| 1275 Mamaroneck Avenue |
| White Plains, NY 10605 |
| Phone: | (914) 997-4488 |
| Web Address: | www.marchofdimes.com |
| |
|
The March of Dimes tries to improve the health of babies by
preventing birth defects, premature birth, and early death. March of Dimes
supports research, community services, education, and advocacy to save babies'
lives. The organization's Web site has information on premature birth, birth
defects, birth defects testing, pregnancy, and prenatal care. You can sign up
to get a free newsletter and also explore Understanding Your Newborn: An
Interactive Program for New Parents.
|
|
| National Heart, Lung, and Blood Institute
(NHLBI) |
|
P.O. Box 30105 |
| Bethesda, MD 20824-0105 |
| Phone: | (301) 592-8573 |
| Fax: | (240) 629-3246 |
| TDD: | (240) 629-3255 |
| E-mail: | nhlbiinfo@nhlbi.nih.gov |
| Web Address: | www.nhlbi.nih.gov |
| |
|
The U.S. National Heart, Lung, and Blood Institute (NHLBI)
information center offers information and publications about preventing and
treating heart, lung, and blood diseases.
|
|
| National Human Genome Research Institute, National
Institutes of Health (NIH) |
| NIH Building 31, Room 4B09, 31 Center Drive |
| MSC 2152, 9000 Rockville Pike |
| Bethesda, MD 20892-2152 |
| Phone: | Phone: (301) 402-0911 |
| Fax: | (301) 402-2218 |
| Web Address: | www.genome.gov |
| |
|
The National Human Genome Research Institute (NHGRI) supports
genetic and genomic research, investigation into the ethical, legal, and social
implications surrounding genetics research, and educational outreach
activities. (Genome refers to a complete gene sequence in a organism.) NHGRI
also supports the training of investigators and provides genome information,
including fact sheets and school materials, to the public and to health
professionals.
|
|
Related Information
References
Citations
-
Lo L, Singer ST (2002). Thalassemia: Current approach
to an old disease. Pediatric Clinics of North America,
49(6): 1165–1191.
-
Borgna-Pignatti C, Galanello R (2004). Thalassemias
and related disorders: Quantitative disorders of hemoglobin synthesis. In JP
Greer et al., eds., Wintrobe's Clinical Hematology, vol.
1, pp. 1319–1365. Philadelphia: Lippincott Williams and Wilkins.
-
Weatherall DJ (2006). Disorders of globin synthesis:
The thalassemias. In M Lichtman et al., eds., Williams
Hematology, 7th ed., pp. 633–666. New York: McGraw-Hill.
-
Vadolas J, et al. (2004). Cellular genomic reporter
assays for screening and evaluation of inducers of fetal hemoglobin.
Human Molecular Genetics, 13(2): 223–233.
Other Works Consulted
-
Hillman RS, Ault KA (2005). Thalassemia. In
Hematology in Clinical Practice, 4th ed., pp. 65–79. New
York: McGraw-Hill.
Credits
| Author | Robin Parks, MS |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Michele Cronen |
| Primary Medical Reviewer | Anne C. Poinier, MD - Internal Medicine |
| Specialist Medical Reviewer | Brian Leber, MDCM, FRCPC - Hematology |
| Last Updated | July 26, 2007 |
|
|
| Author: | Robin Parks, MS | Last Updated: July 26, 2007 |
| Medical Review: | Anne C. Poinier, MD - Internal Medicine
Brian Leber, MDCM, FRCPC - Hematology |
|
|
|
© 1995-2008, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|